Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved primate foamy virus vectors and packaging constructs.

Martin Heinkelein1, Marco Dressler, Gergely Jármy

  • 1Institut für Virologie und Immunbiologie, Universität Würzburg, Germany.

Journal of Virology
|March 22, 2002
PubMed
Summary

Researchers engineered foamy virus (FV) vectors with reduced genetic material and minimal residual gene expression. They identified a key regulatory element in the FV 5' splice donor site, enabling improved vector design for efficient gene transfer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional dissection of the prototype foamy virus glycoprotein heparan sulfate binding site.

Retrovirology·2026
Same author

Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Thirteenth International Foamy Virus Conference-Meeting Report.

Viruses·2025
Same author

Furosemide Reduces Radionuclide Activity in the Bladder in <sup>18</sup>F-PSMA-1007-PET/CT: A Single-Center Retrospective Intra-Individual Comparative Study.

Diagnostics (Basel, Switzerland)·2025
Same author

2024 taxonomy update for the family Retroviridae.

Archives of virology·2025
Same author

Timed chromatin invasion during mitosis governs prototype foamy virus integration site selection and infectivity.

Nucleic acids research·2025

Area of Science:

  • * Molecular Biology
  • * Virology
  • * Gene Therapy

Background:

  • * Foamy virus (FV) vectors are promising tools for gene therapy.
  • * Previous studies highlighted the importance of the R region in the long terminal repeat for FV gag gene expression.
  • * Efficient incorporation of packaging construct RNA into vector particles is crucial for vector production.

Purpose of the Study:

  • * To construct and analyze foamy virus (FV) vectors with minimal cis-acting sequences and reduced viral gene expression.
  • * To identify the regulatory role of the 5' splice donor (SD) site in FV gag gene expression.
  • * To improve FV vector design for efficient gene transfer and reduced non-vector RNA incorporation.

Main Methods:

  • * Construction of FV vectors using a transient cotransfection packaging system.

Related Experiment Videos

  • * Analysis of FV gag gene expression regulation by the 5' splice donor (SD) site.
  • * Replacement of the native FV 5' SD with heterologous splice sites (HIV 5' SD, unrelated intron).
  • * Separation of gag and pol gene expression onto different plasmids.

    • Main Results:

    • * The 5' splice donor (SD) site in the R region was identified as a key regulator of FV gag gene expression.
    • * Replacing the FV 5' SD with heterologous splice sites allowed for gag and pol gene expression.
    • * Substituting the FV 5' untranslated region with HIV 5' SD or an intron sequence significantly reduced non-vector RNA incorporation.
    • * Separating gag and pol expression on distinct plasmids further minimized non-vector RNA levels.

    Conclusions:

    • * The 5' splice donor (SD) site plays a critical regulatory role in FV gene expression.
    • * Modified FV vectors with heterologous splice sites and separated gene expression demonstrate improved efficiency and safety.
    • * These engineered FV vectors offer a promising strategy for efficient gene transfer with minimal genetic overlap.